Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Magnesium Sulphate Halves Risk Of Eclampsia And Can Save Lives Of Pregnant Women

31.05.2002


Giving magnesium sulphate injections to pregnant women with pre-eclampsia halves the risk of eclampsia developing and can save their lives. This is the conclusion of a major international clinical trial funded by the Medical Research Council (MRC) and published in this week’s The Lancet.



The three-year £2.5 million study, the ‘Magpie’* Trial, was conducted in 33 countries spanning the UK and much of the developing world where eclampsia is the most common cause of death for pregnant women. The trial involved over 10,000 women.

All of the women were suffering from pre-eclampsia (pregnancy-induced high blood pressure, commonly known as toxaemia) which can lead to eclampsia (convulsions) which threatens both the mother’s and the baby’s lives.


In addition to normal medical care, half the women in the trial were randomly assigned to receive an injection of magnesium sulphate, an anticonvulsant drug. The other half was allocated a placebo treatment.

Women allocated magnesium sulphate had a 58% lower risk of eclampsia than those allocated the placebo. Although the treatment did not affect whether or not the baby died, there was evidence that it can reduce the risk of the mother dying. A quarter of women reported minor side effects but there was no evidence of harmful effects to either the mother or baby.

Dr Lelia Duley, an MRC Senior Clinical Fellow and Obstetric Epidemiologist in the Institute of Health Sciences at the University of Oxford, led the research.

She said: “Eclampsia is a devastating condition that can kill both mother and child. Our trial has shown that giving magnesium sulphate injections halves the risk of developing eclampsia for women who already have pre-eclampsia, and it seems likely it also reduces the risk of maternal death. The treatment could save countless lives across the world if it was introduced routinely for pregnant women with pre-eclampsia. And, importantly, it is a very inexpensive treatment, making it especially suitable for use in low income countries.”

Professor Jim Neilson, Professor of Obstetrics and Gynaecology at the University of Liverpool, was one of the clinicians who worked on the trial. He said: “Anticonvulsant drugs have been given to some women with pre-eclampsia for several years but this is the first time that we’ve shown clear benefits for magnesium sulphate treatment through a major research study. These exciting results should now change routine clinical practice across the UK and the world.”

Claire Giles, a woman who suffered pre-eclampsia during her first pregnancy and who took part in the trial, said: “I was really pleased to be part of such an important trial. I developed swelling at 32 weeks which grew progressively more severe until I was finally diagnosed with pre-eclampsia and admitted to hospital at 38 weeks. My baby was delivered by caesarean section and thankfully we both made a complete recovery. Pre-eclampsia is a frightening condition and I really hope that the results of the trial will benefit women like me.”

One in ten pregnant women world-wide suffers from pre-eclampsia, often in their first pregnancy. Currently the only definitive treatment is to deliver the baby early. Once the baby is born the mother’s blood pressure usually returns to normal although the baby will often require intensive medical care due to being born prematurely.

Women seeking further information about pre-eclampsia and eclampsia can call the Action on Pre-eclampsia (APEC) Helpline on 020 8427 4217 (weekdays 10am - 1pm).

The research was funded mainly by the Medical Research Council with support from the Department for International Development, the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction and the European Commission, DG Research, INCO Programme.

Press Office | alphagalileo

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

 
Latest News

New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development

28.09.2016 | Medical Engineering

Innovate coating extends the life of materials for industrial use

28.09.2016 | Materials Sciences

Blockchain Set to Transform the Financial Services Market

28.09.2016 | Business and Finance

VideoLinks
B2B-VideoLinks
More VideoLinks >>>